Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Hardcastle, Sharni Lee, Brenu, Ekua Weba, Johnston, Samantha et al. · BMC immunology · 2015 · DOI
Quick Summary
This study examined immune system cells from people with moderate and severe ME/CFS compared to healthy controls. Researchers found that people with ME/CFS had abnormal patterns in their immune cells, including changes in markers on T cells, NK cells, and other infection-fighting cells. These differences were more pronounced in people with more severe illness, suggesting that immune dysfunction may be connected to ME/CFS severity.
Why It Matters
Identifying specific immune cell abnormalities in ME/CFS provides objective biological markers that could help validate the disease and differentiate severity levels. Understanding which immune pathways are dysregulated is essential for developing targeted treatments and may explain why ME/CFS patients experience persistent illness and post-exertional symptom worsening.
Observed Findings
Moderate CFS/ME patients had increased CD8+ CD45RA effector memory T cells and SLAM expression on NK cells compared to controls
Moderate CFS/ME patients showed reduced CD8+ T central memory LFA-1, total CD8+ KLRG1, and other adhesion/activation markers
Severe CFS/ME patients exhibited increased CD18+CD11c- in CD56dim NK cells and reduced NKp46 in CD56bright NK cells
Different immune profiles distinguished moderate from severe CFS/ME, with severity-dependent changes in T and NK cell receptor expression
Multiple receptor abnormalities were present across both innate (NK, monocytes) and adaptive (T cell) immune compartments
Inferred Conclusions
ME/CFS is associated with measurable immune cell dysfunction affecting both innate and adaptive immunity
Immune abnormalities differ between moderate and severe disease, suggesting immune dysregulation correlates with illness severity
Altered T and NK cell receptor expression and adhesion markers may impair immune cell communication and function in ME/CFS
Functional immunological assessment is necessary to characterize the complex pathophysiology underlying ME/CFS
Remaining Questions
Do these immune abnormalities precede ME/CFS onset or develop secondary to illness, and do they change with disease progression?
What This Study Does Not Prove
This study does not prove that these immune abnormalities cause ME/CFS—it shows an association only. The findings cannot be generalized to all ME/CFS patients due to small sample size and lack of longitudinal data. The study does not demonstrate whether these immune changes are primary drivers of illness or secondary consequences of chronic disease.